Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,090 across all filing types
Latest filing 2022-10-12 Major Shareholding Noti…
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree. This specific form is used to disclose positions and dealings in securities during an M&A process. While it relates to M&A activity, it is a specific regulatory disclosure form rather than a general M&A announcement (TAR). Given the specific nature of the 'Form 8.3' disclosure and its regulatory purpose, it falls under the category of Regulatory Filings (RNS).
2022-10-12 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details shareholdings, derivative positions, and recent dealings. This specific type of disclosure is a mandatory regulatory requirement for market transparency during M&A activity and is classified under the 'Major Shareholding Notification' category as it tracks significant ownership thresholds and changes.
2022-10-11 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 97% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details positions and dealings in the securities of Mediclinic International plc by Citadel Group. Since this is a specific regulatory disclosure regarding shareholdings and dealings during a takeover period, it falls under the 'Regulatory Filings' category as it does not fit into the more specific categories like 'Major Shareholding Notification' (which usually refers to crossing thresholds in a non-takeover context) or 'Director's Dealing'.
2022-10-10 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 95% confidence The document is a 'FORM 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree. It details positions and dealings in the securities of Mediclinic International plc by Citadel Group. Since this is a specific regulatory disclosure regarding shareholdings and dealings during a takeover period, it falls under the 'Major Shareholding Notification' category, which covers notifications of significant ownership levels and related disclosures.
2022-10-07 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree. It details positions and dealings in the securities of Mediclinic International plc by Citadel Group. This type of disclosure is a specific regulatory requirement for M&A-related activity and is classified as a Major Shareholding Notification (MRQ) as it pertains to significant share ownership and dealing disclosures.
2022-10-06 English
Form 8.3 - Mediclinic International plc
Regulatory Filings Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more during an offer period. It details shareholdings, derivatives, and dealings in the securities of Mediclinic International plc by Citadel Group. This is a specific regulatory disclosure document, not a report publication announcement or a general corporate filing, and fits the 'Regulatory Filings' (RNS) category as it is a mandatory disclosure submitted to a Regulatory Information Service.
2022-10-05 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.